SUT BEZI SARATONI BILAN KASALLANGAN BEMORLARDA AKSILYAR LIMFA TUGUNLARI ZARARLANISHINING KLINIK VA PATOLOGIK BAHOLANISHI

Z.A Sobirjonova; U.M. Kurbankulov; B.A Choriyev

Vol. 2 No. 6 (2025), Articles

Vol. 2 No. 6 (2025)

SUT BEZI SARATONI BILAN KASALLANGAN BEMORLARDA AKSILYAR LIMFA TUGUNLARI ZARARLANISHINING KLINIK VA PATOLOGIK BAHOLANISHI

Articles

Published 2025-06-20

Sobirjonova Z.A⁺⁻
Kurbankulov U.M.⁺⁻
Choriyev B.A ⁺⁻

Sobirjonova Z.A

RESPUBLIKA IXTISOSLASHTIRILGAN ONKOLOGIYA VA RADIOLOGIYA ILMIY-AMALIY TIBBIY MARKAZI (RIORIATM), TOSHKENT SHAHAR FILIALI, ONKOLOGIYA KAFEDRASI Toshkent, O‘zbekiston

Kurbankulov U.M.

Ilmiy rahbar: PhD

Choriyev B.A

Ilmiy maslahatchi RESPUBLIKA IXTISOSLASHTIRILGAN ONKOLOGIYA VA RADIOLOGIYA ILMIY-AMALIY TIBBIY MARKAZI (RIORIATM), TOSHKENT SHAHAR FILIALI, ONKOLOGIYA KAFEDRASI Toshkent, O‘zbekiston

PDF

DOI

How to Cite

SUT BEZI SARATONI BILAN KASALLANGAN BEMORLARDA AKSILYAR LIMFA TUGUNLARI ZARARLANISHINING KLINIK VA PATOLOGIK BAHOLANISHI. (2025). CONFERENCE OF NATURAL AND APPLIED SCIENCES IN SCIENTIFIC INNOVATIVE RESEARCH, 2(6), 96-99. https://www.universalpublishings.com/index.php/cnassir/article/view/12731

Abstract

Sut bezi saratoni (SBS) global miqyosda ayollar orasida eng keng tarqalgan malign neoplazma sifatida qayd etilib, 2020-yilda dunyo bo‘yicha 2,3 milliondan ortiq yangi holat va 685,000 ga yaqin o‘lim holati ro‘yxatga olingan (Sung et al., 2021). O‘zbekistonda ham SBS onkologik kasalliklar orasida yetakchi o‘rinlardan birini egallab, ayollar salomatligiga jiddiy xavf solmoqda

PDF

DOI

References

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.

2. Giuliano AE, Edge SB, Hortobagyi GN. Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer. Ann Surg Oncol. 2018 Jul;25(7):1783-1785. doi: 10.1245/s10434-018-6486-6. Epub 2018 Apr 18. PMID: 29671136.

3. Houssami N, Ciatto S, Turner RM, Cody HS 3rd, Macaskill P. Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axilla. Ann Surg. 2011 Aug;254(2):243-51. doi: 10.1097/SLA.0b013e31821f1564. PMID: 21597359.

4. Rao R, Euhus D, Mayo HG, Balch C. Axillary node interventions in breast cancer: a systematic review. JAMA. 2013 Oct 2;310(13):1385-94. doi: 10.1001/jama.2013.277804. PMID: 24084924.

5. Veronesi, Umberto & Paganelli, Giovanni & Viale, Giuseppe & Luini, Alberto & Zurrida, Stefano & Galimberti, Viviana & Intra, Mattia & Veronesi, Paolo & Robertson, Chris & Maisonneuve, Patrick & Renne, Giuseppe & Cicco, Concetta & Lucia, Francesca & Gennari, Roberto. (2003). A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer. The New England journal of medicine. 349. 546-53. 10.1056/NEJMoa012782.

6. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HM, Wolmark N. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010 Oct;11(10):927-33. doi: 10.1016/S1470-2045(10)70207-2. PMID: 20863759; PMCID: PMC3041644.